| RS2494757458 |
RAG1
|
Health Risk |
Pathogenic |
Combined immunodeficiency with skin granulomas, Severe combined immunodeficiency |
| RS2494758555 |
RAG1
|
Health Risk |
Pathogenic |
Combined immunodeficiency with skin granulomas, Severe combined immunodeficiency |
| RS2494758617 |
RAG1
|
Health Risk |
Pathogenic |
Combined immunodeficiency with skin granulomas, Severe combined immunodeficiency |
| RS2494759199 |
RAG1
|
Health Risk |
Pathogenic |
Combined immunodeficiency with skin granulomas, Severe combined immunodeficiency |
| RS2494759451 |
RAG1
|
Health Risk |
Pathogenic |
Combined immunodeficiency with skin granulomas, Severe combined immunodeficiency |
| RS2494760163 |
RAG1
|
Health Risk |
Pathogenic |
Severe combined immunodeficiency, autosomal recessive |
| RS2494760278 |
RAG1
|
Health Risk |
Pathogenic |
Combined immunodeficiency with skin granulomas, Severe combined immunodeficiency |
| RS2494760363 |
RAG1
|
Health Risk |
Pathogenic/Likely pathogenic |
Combined immunodeficiency due to partial RAG1 deficiency, Severe combined immunodeficiency |
| RS2494760396 |
RAG1
|
Health Risk |
Pathogenic |
Combined immunodeficiency with skin granulomas, Severe combined immunodeficiency |
| RS2494760674 |
RAG1
|
Health Risk |
Likely pathogenic |
Combined immunodeficiency due to partial RAG1 deficiency, Combined immunodeficiency due to partial RAG1 deficiency |
| RS2494760982 |
RAG1
|
Health Risk |
Pathogenic |
Combined immunodeficiency with skin granulomas, Severe combined immunodeficiency |
| RS2494761283 |
RAG1
|
Health Risk |
Pathogenic |
Combined immunodeficiency due to partial RAG1 deficiency, Combined immunodeficiency due to partial RAG1 deficiency |
| RS2494761308 |
RAG1
|
Health Risk |
Pathogenic |
Combined immunodeficiency with skin granulomas, Severe combined immunodeficiency |
| RS2494762182 |
RAG1
|
Health Risk |
Likely pathogenic |
Combined immunodeficiency due to partial RAG1 deficiency, Combined immunodeficiency due to partial RAG1 deficiency |
| RS2494762661 |
RAG1
|
Health Risk |
Pathogenic |
Combined immunodeficiency with skin granulomas, Severe combined immunodeficiency |
| RS2494763949 |
CHST3
|
Health Risk |
Pathogenic |
Spondyloepiphyseal dysplasia with congenital joint dislocations, Spondyloepiphyseal dysplasia with congenital joint dislocations |
| RS2494765841 |
HPS5
|
Health Risk |
Pathogenic |
— |
| RS2494767083 |
CHST3
|
Health Risk |
Likely pathogenic |
Spondyloepiphyseal dysplasia with congenital joint dislocations, Spondyloepiphyseal dysplasia with congenital joint dislocations |
| RS2494768200 |
CHST3
|
Health Risk |
Pathogenic/Likely pathogenic |
Spondyloepiphyseal dysplasia with congenital joint dislocations, Spondyloepiphyseal dysplasia with congenital joint dislocations |
| RS2494771271 |
CHST3
|
Health Risk |
Pathogenic |
Spondyloepiphyseal dysplasia with congenital joint dislocations, Spondyloepiphyseal dysplasia with congenital joint dislocations |
| RS2494772065 |
CHST3
|
Health Risk |
Pathogenic |
Spondyloepiphyseal dysplasia with congenital joint dislocations, Spondyloepiphyseal dysplasia with congenital joint dislocations |
| RS2494783688 |
PDHX
|
Health Risk |
Likely pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2494786655 |
RAG2
|
Health Risk |
Pathogenic |
Combined immunodeficiency with skin granulomas, Severe combined immunodeficiency |
| RS2494787994 |
RAG2
|
Health Risk |
Pathogenic |
Severe combined immunodeficiency, autosomal recessive |
| RS2494788127 |
RAG2
|
Health Risk |
Pathogenic |
Combined immunodeficiency with skin granulomas, Severe combined immunodeficiency |
| RS2494788285 |
RAG2
|
Health Risk |
Pathogenic |
Combined immunodeficiency with skin granulomas, Severe combined immunodeficiency |
| RS2494788679 |
RAG2
|
Health Risk |
Likely pathogenic |
Combined immunodeficiency with skin granulomas, Severe combined immunodeficiency |
| RS2494789497 |
RAG2
|
Health Risk |
Pathogenic |
Combined immunodeficiency with skin granulomas, Severe combined immunodeficiency |
| RS2494790291 |
RAG2
|
Health Risk |
Pathogenic |
Severe combined immunodeficiency, autosomal recessive |
| RS2494790882 |
RAG2
|
Health Risk |
Likely pathogenic |
— |
| RS2494790954 |
ANO5
|
Health Risk |
Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2L, Gnathodiaphyseal dysplasia |
| RS2494791063 |
RAG2
|
Health Risk |
Pathogenic |
Combined immunodeficiency with skin granulomas, Severe combined immunodeficiency |
| RS2494791448 |
RAG2
|
Health Risk |
Pathogenic |
Severe combined immunodeficiency, autosomal recessive |
| RS2494791806 |
RAG2
|
Health Risk |
Pathogenic |
Combined immunodeficiency with skin granulomas, Severe combined immunodeficiency |
| RS2494791825 |
RAG2
|
Health Risk |
Likely pathogenic |
Combined immunodeficiency with skin granulomas, Combined immunodeficiency with skin granulomas |
| RS2494792018 |
RAG2
|
Health Risk |
Likely pathogenic |
Combined immunodeficiency with skin granulomas, Combined immunodeficiency with skin granulomas |
| RS2494793071 |
RAG2
|
Health Risk |
Likely pathogenic |
Combined immunodeficiency with skin granulomas, Combined immunodeficiency with skin granulomas |
| RS2494794279 |
RAG2
|
Health Risk |
Likely pathogenic |
Combined immunodeficiency with skin granulomas, Combined immunodeficiency with skin granulomas |
| RS2494794434 |
RAG2
|
Health Risk |
Likely pathogenic |
Severe combined immunodeficiency, autosomal recessive |
| RS2494795418 |
RAG2
|
Health Risk |
Pathogenic/Likely pathogenic |
Combined immunodeficiency with skin granulomas, Severe combined immunodeficiency |
| RS2494797251 |
RAG2
|
Health Risk |
Pathogenic |
Combined immunodeficiency with skin granulomas, Severe combined immunodeficiency |
| RS2494797733 |
FAS
|
Health Risk |
Conflicting classifications of pathogenicity |
Autoimmune lymphoproliferative syndrome type 1, Inborn genetic diseases |
| RS2494798051 |
RAG2
|
Health Risk |
Conflicting classifications of pathogenicity |
Severe combined immunodeficiency, autosomal recessive |
| RS2494798134 |
RAG2
|
Health Risk |
Pathogenic |
Combined immunodeficiency with skin granulomas, Severe combined immunodeficiency |
| RS2494799074 |
RAG2
|
Health Risk |
Pathogenic |
Severe combined immunodeficiency, autosomal recessive |
| RS2494799242 |
RAG2
|
Health Risk |
Pathogenic |
Combined immunodeficiency with skin granulomas, Combined immunodeficiency with skin granulomas |
| RS2494799758 |
RAG2
|
Health Risk |
Likely pathogenic |
Combined immunodeficiency with skin granulomas, Severe combined immunodeficiency |
| RS2494799990 |
RAG2
|
Health Risk |
Likely pathogenic |
Combined immunodeficiency with skin granulomas, Severe combined immunodeficiency |
| RS2494800093 |
SBF2
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease type 4, Charcot-Marie-Tooth disease type 4 |
| RS2494800686 |
RAG2
|
Health Risk |
Likely pathogenic |
Combined immunodeficiency with skin granulomas, Combined immunodeficiency with skin granulomas |
| RS2494800701 |
RAG2
|
Health Risk |
Likely pathogenic |
Combined immunodeficiency with skin granulomas, Combined immunodeficiency with skin granulomas |
| RS2494801025 |
RAG2
|
Health Risk |
Likely pathogenic |
Combined immunodeficiency with skin granulomas, Severe combined immunodeficiency |
| RS2494825871 |
WT1
|
Health Risk |
Pathogenic |
Drash syndrome, Frasier syndrome |
| RS2494853019 |
CHRNE
|
Health Risk |
Likely pathogenic |
Congenital myasthenic syndrome 4A, Congenital myasthenic syndrome 4A |
| RS2494859893 |
FANCF
|
Health Risk |
Likely pathogenic |
Fanconi anemia complementation group F, Fanconi anemia complementation group F |
| RS2494861863 |
FANCF
|
Health Risk |
Likely pathogenic |
Fanconi anemia complementation group F, Fanconi anemia complementation group F |
| RS2494863251 |
FANCF
|
Health Risk |
Likely pathogenic |
Fanconi anemia complementation group F, Fanconi anemia complementation group F |
| RS2494864133 |
FANCF
|
Health Risk |
Likely pathogenic |
Fanconi anemia complementation group F, Fanconi anemia complementation group F |
| RS2494865086 |
FANCF
|
Health Risk |
Likely pathogenic |
Fanconi anemia complementation group F, Fanconi anemia complementation group F |
| RS2494866075 |
FANCF
|
Health Risk |
Pathogenic |
Fanconi anemia, Fanconi anemia complementation group F |
| RS2494867744 |
FANCF
|
Health Risk |
Pathogenic/Likely pathogenic |
Fanconi anemia complementation group F, Fanconi anemia |
| RS2494868833 |
FANCF
|
Health Risk |
Likely pathogenic |
Fanconi anemia complementation group F, Fanconi anemia complementation group F |
| RS2494869728 |
FANCF
|
Health Risk |
Pathogenic |
Fanconi anemia, Fanconi anemia |
| RS2494870839 |
FANCF
|
Health Risk |
Pathogenic/Likely pathogenic |
Fanconi anemia complementation group F, Fanconi anemia |
| RS2494871401 |
FANCF
|
Health Risk |
Pathogenic |
Fanconi anemia, Fanconi anemia |
| RS2494871663 |
FANCF
|
Health Risk |
Pathogenic |
Fanconi anemia, Fanconi anemia |
| RS2494874800 |
PEX16
|
Health Risk |
Pathogenic |
Peroxisome biogenesis disorder 8B, Peroxisome biogenesis disorder 8B |
| RS2494889270 |
NT5C2
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 45, Hereditary spastic paraplegia 45 |
| RS2494892546 |
PEX16
|
Health Risk |
Pathogenic |
Peroxisome biogenesis disorder, Peroxisome biogenesis disorder |
| RS2494894653 |
PEX16
|
Health Risk |
Pathogenic |
Peroxisome biogenesis disorder, Peroxisome biogenesis disorder |
| RS2494894758 |
PEX16
|
Health Risk |
Pathogenic |
Peroxisome biogenesis disorder, Peroxisome biogenesis disorder |
| RS2494901293 |
SBF2
|
Health Risk |
Likely pathogenic |
Charcot-Marie-Tooth disease type 4B2, Charcot-Marie-Tooth disease type 4B2 |
| RS2494902317 |
SBF2
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease type 4, Charcot-Marie-Tooth disease type 4 |
| RS2494905042 |
PEX16
|
Health Risk |
Pathogenic |
Peroxisome biogenesis disorder, Peroxisome biogenesis disorder |
| RS2494905864 |
PEX16
|
Health Risk |
Likely pathogenic |
Peroxisome biogenesis disorder, Ovarian serous cystadenocarcinoma |
| RS2494908941 |
PEX16
|
Health Risk |
Likely pathogenic |
Peroxisome biogenesis disorder, Peroxisome biogenesis disorder |
| RS2494917564 |
PEX16
|
Health Risk |
Pathogenic |
Peroxisome biogenesis disorder, Peroxisome biogenesis disorder |
| RS2495021186 |
FAS
|
Health Risk |
Pathogenic |
Autoimmune lymphoproliferative syndrome type 1, Autoimmune lymphoproliferative syndrome type 1 |
| RS2495048635 |
PAX6
|
Health Risk |
Pathogenic |
Aniridia 1, Aniridia 1 |
| RS2495048806 |
TMX2
|
Health Risk |
Likely pathogenic |
Neurodevelopmental disorder with microcephaly, cortical malformations |
| RS2495056510 |
PAX6
|
Health Risk |
Pathogenic |
Aniridia 1, Irido-corneo-trabecular dysgenesis |
| RS2495061780 |
PAX6
|
Health Risk |
Pathogenic |
Aniridia 1, Aniridia 1 |
| RS2495062112 |
PAX6
|
Health Risk |
Pathogenic |
Congenital aniridia, Congenital aniridia |
| RS2495062228 |
SLC25A22
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2495066264 |
PAX6
|
Health Risk |
Pathogenic |
Irido-corneo-trabecular dysgenesis, Aniridia 1 |
| RS2495069375 |
PAX6
|
Health Risk |
Pathogenic |
Aniridia 1, Irido-corneo-trabecular dysgenesis |
| RS2495074114 |
PCDH15
|
Health Risk |
Likely pathogenic |
Usher syndrome type 1D, Usher syndrome type 1D |
| RS2495077510 |
PAX6
|
Health Risk |
Likely pathogenic |
Aniridia 1, Irido-corneo-trabecular dysgenesis |
| RS2495078256 |
PCDH15
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal recessive nonsyndromic hearing loss 23, Usher syndrome type 1D |
| RS2495097530 |
PAX6
|
Health Risk |
Pathogenic |
Aniridia 1, Irido-corneo-trabecular dysgenesis |
| RS2495102207 |
FAS
|
Health Risk |
Pathogenic |
Autoimmune lymphoproliferative syndrome type 1, Autoimmune lymphoproliferative syndrome type 1 |
| RS2495105858 |
PAX6
|
Health Risk |
Pathogenic |
Aniridia 1, Irido-corneo-trabecular dysgenesis |
| RS2495115392 |
PAX6
|
Health Risk |
Pathogenic |
— |
| RS2495116340 |
PAX6
|
Health Risk |
Pathogenic |
— |
| RS2495121485 |
FAS
|
Health Risk |
Pathogenic |
Autoimmune lymphoproliferative syndrome type 1, Autoimmune lymphoproliferative syndrome type 1 |
| RS2495121695 |
PAX6
|
Health Risk |
Likely pathogenic |
Aniridia 1, Aniridia 1 |
| RS2495122596 |
FAS
|
Health Risk |
Pathogenic |
Autoimmune lymphoproliferative syndrome type 1, Autoimmune lymphoproliferative syndrome type 1 |
| RS2495123636 |
PAX6
|
Health Risk |
Pathogenic |
Coloboma, ocular |
| RS2495134983 |
PCDH15
|
Health Risk |
Likely pathogenic |
Autosomal recessive nonsyndromic hearing loss 23, Autosomal recessive nonsyndromic hearing loss 23 |
| RS2495137682 |
PCDH15
|
Health Risk |
Likely pathogenic |
Usher syndrome type 1D, Usher syndrome type 1D |